CBP20 Polyclonal Antibody

The product of NCBP2 is a component of the nuclear cap-binding protein complex (CBC), which binds to the monomethylated 5' cap of nascent pre-mRNA in the nucleoplasm. The encoded protein (nuclear cap binding protein subunit 2) has an RNP domain commonly found in RNA binding proteins, and contains the cap-binding activity. The CBC promotes pre-mRNA splicing, 3'-end processing, RNA nuclear export, and nonsense-mediated mRNA decay. Multiple transcript variants encoding different isoforms have been found for NCBP2.

The CBP20 Polyclonal Antibody is a highly specific and sensitive antibody designed for use in a variety of research applications. This antibody is produced using a polyclonal approach, which ensures a high degree of specificity and sensitivity. The CBP20 Polyclonal Antibody is designed to recognize and bind to the CBP20 protein, which is a key component of the cap-binding complex (CBC) that is involved in the regulation of mRNA translation. This antibody has been extensively validated for use in Western blotting, immunoprecipitation, and immunofluorescence assays, and has been shown to provide reliable and reproducible results. The CBP20 Polyclonal Antibody is supplied in a convenient format, with a range of sizes available to suit your specific needs. This antibody is an essential tool for researchers studying the regulation of mRNA translation and the role of the CBC in this process.